Keyword [SHP2]
Result: 101 - 120 | Page: 6 of 7 |
| 101. | Discovery Of Novel SHP2 Inhibitors |
| 102. | Discovery Of SHP2 Small Molecule Degraders And Its Anti-tumor Effect Exploration |
| 103. | Design,synthesis And Activity Evaluation Of Novel SHP1/SHP2 Inhibitors Containing Five-membered Heterocyclic Structure Unit |
| 104. | Design, Synthesis And Activity Evaluation Of SHP2 Inhibitors Containing Oxadiazole Structural Units |
| 105. | Effect Of SHP2 Expression Changes On Collagen Metabollsm In Liver Tissues Of Rats With Hepatic Fibrosis |
| 106. | Effect Of SHP2 Expression Changes On The Activation And Proliferation Of Hepatic Stellate Cells In Vivo |
| 107. | The Mechanism Of Endothelial Shp2 In Regulating Radiation-induced Pulmonary Fibrosis |
| 108. | The Role Of Multidisciplinary In The Diagnosis And Therapy Of Gastric Cancer |
| 109. | Synergistic Lethal Effects And Mechanism Of Combined Inhibition Of WWP1 And SHP2 In Colorectal Cancer |
| 110. | The Regulation And Mechanism Of E3 Ubiquitin Ligase NEDD4L On Stemness In Hepatocellular Carcinoma |
| 111. | SHP2 Allosteric Inhibitor Batoprotafib Inhibits Proliferation Of Imatinib-resistant Gastrointestinal Stromal Tumor (GIST) And The Comprehensive Analyses Of Treatment Strategies For GIST |
| 112. | Study On The Role And Mechanism Of SHP2 And Obese Tumor Microenvironment Derived OLCarn In Breast Cancer |
| 113. | Study On The Role And Correlation Of SHP2,STAT3,CTCs In Early DTC |
| 114. | The Role And Mechanism Of SHP2 In EGFR-TKI Resistance In Non-small Cell Lung Cancer |
| 115. | Role And Mechanism Of E3 Ubiquitin Ligase RNF183 In The Cell Proliferation And Apoptosis Of Lung Adenocarcinoma |
| 116. | Study On The Pharmacy, Pharmacokinetics And Preliminary Effects Of Realgar And Its Compatibility On K562 Cell |
| 117. | Study On Antitumor Activity And Mechanism Of Bromophenol Compound LXQ-217 Targeting SHP2 |
| 118. | Design,Synthesis And Biological Evaluation Of 1,2,4-Triazolo[3,4-b][1,3,4]-Thiadiazole Derivatives |
| 119. | Expression And Clinical Study Of Gab1 And SHP2 In Thyroid Papillary Carcinoma |
| 120. | Dual Targeting SHP2 And EphA2 Synergistically Inhibits Colorectal Cancer |
|
